companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

SERONO SYMPOSIA USA; INC

NORTH SCITUATE-USA

Company Name:
Corporate Name:
SERONO SYMPOSIA USA; INC
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 100 Longwater Circle,NORTH SCITUATE,MA,USA 
ZIP Code:
Postal Code:
2060 
Telephone Number: 7816812137 (+1-781-681-2137) 
Fax Number: 7819829481 (+1-781-982-9481) 
Website:
aboutseronosymposia. com;aboutseronosymposiaeducationaltv. com;seronosymposia. cc;seronosymposia. com;se 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
4833 
USA SIC Description:
Television stations 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
BARNETT;MICHAEL
TARGET MARKETING GROUP
JOSEPH ZIBRAK
Next company profile:
MATT POWER
MASSACHUSETTS CAMPING ASSOCIATION
COMPUTERSMITHS CONSULTING










Company News:
  • English Home - EMD Serono
    EMD Serono is a specialty innovator that helps create, improve and prolong lives for people living with infertility, multiple sclerosis and cancer
  • About EMD Serono: The Healthcare Business of Merck KGaA, Darmstadt . . .
    At EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany in the U S , we work to transform lives by developing and delivering meaningful therapies, and working to truly understand and respond to the therapeutic and support needs of individual patients
  • Who we are - Company | EMD Serono
    At EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany in the U S , we aspire to create, improve and prolong life for people living with difficult-to-treat conditions like infertility, multiple sclerosis and cancer
  • Global Organization - EMD Serono
    EMD Serono is the healthcare business of Merck KGaA, Darmstadt, Germany, in the United States and Canada This connection to our global business allows us to leverage resources that optimize the delivery of products and services to customers and patients in the U S
  • Research - EMD Serono
    EMD Serono researchers strive to identify novel scientific opportunities that may translate into tangible value for patients living with serious unmet medical needs
  • Fertility - EMD Serono
    EMD Serono has a 25+ year legacy in helping people who are struggling to grow their family Discover our commitment to supporting families impacted by infertility
  • Neurology Immunology - EMD Serono
    At EMD Serono, we have a long-standing legacy in neurology and immunology, with vast R D and commercial experience in multiple sclerosis over more than 20 years
  • History - EMD Serono
    Today Today, Merck KGaA, Darmstadt, Germany holds the global rights to the "Merck" name and brand The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials Learn More
  • Expertise - EMD Serono
    EMD Serono has a proven legacy of delivering meaningful therapies for people living with difficult-to-treat diseases Explore our solutions
  • 2025-06-11 Enpatoran Phase 2 Data from Cohort B in SLE - EMD Serono
    EMD Serono today announced the presentation of detailed results from Cohort B of the global Phase 2 WILLOW study (NCT05162586) evaluating enpatoran, an investigational, oral, novel TLR7 8 inhibitor in systemic lupus erythematosus (SLE)




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer